Year: 2014
Type: article
Abstract: Human thymus is completely developed in late fetal stages and its function peaks in newborns. After the first year of life, the thymus undergoes a progressive atrophy that dramatically decreases de novo T-lymphocyte maturation. Hormonal signaling and changes in the microRNA expression network are identified as underlying causes of human thymus involution. However, specific pathways involved in the age-related loss of thymic function remain unknown. In this study, we analyzed differential gene-expression profile and microRNA expression in elderly (70 years old) and young (less than 10 months old and 11 years old) human thymic samples. Our data have shown that WNT pathway deregulation through the overexpression of different inhibitors by the nonadipocytic component of the human thymus stimulates the age-related involution. These results are of particular interest because interference of WNT signaling has been demonstrated in both animal models and in vitro studies, with the three major hallmarks of thymic involution: (i) epithelial structure disruption, (ii) adipogenic process, and (iii) thymocyte development arrest. Thus, our results suggest that secreted inhibitors of the WNT pathway could be explored as a novel therapeutical target in the reversal of the age-related thymic involution.
Institutions: Consejo Superior de Investigaciones Científicas, Hospital General Universitario Gregorio Marañón, Biomedical Research Networking Center in Bioengineering, Biomaterials and Nanomedicine, Instituto de Biomedicina de Sevilla, Hospital Universitario Virgen del Rocío, Instituto de Investigación Sanitaria Gregorio Marañón, Universidad de Sevilla, BOKU University, University of Warwick
Language: English
Topic: T-cell and B-cell Immunology
Subfield: Immunology
Field: Immunology and Microbiology
Domain: Life Sciences
Open Access status: bronze
Awards: Immunobiology of Allogeneic Hematopoietic Cell Transplantation, Strategies to Enhance Lymphoid Recovery After Radiation-Induced Injury, Strategies to enhance immune reconstitution after bone marrow transplant, T cell homing in intestinal graft-versus-host disease, IL-22 in Thymic Regeneration, Cancer Center Support Grant
OpenAlex ID: W2167459459
